Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Colorectal Neoplasms 199Rectal Neoplasms 106Colonic Neoplasms 78Stomach Neoplasms 64Pancreatic Neoplasms 56Neoplasm Metastasis 50Esophageal Neoplasms 34Neoplasms 25Lymphoma 24Leukemia 24Adenocarcinoma Of Esophagus 22Burkitt Lymphoma 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Carcinoma, Hepatocellular 16Cholangiocarcinoma 15Adenocarcinoma 15Biliary Tract Neoplasms 12Gallbladder Neoplasms 9Bile Duct Neoplasms 8Lymphoma, Mantle-Cell 7Colorectal Cancer Metastatic 7Osteosarcoma 6Esophageal Squamous Cell Carcinoma 6Lymphoma, Non-Hodgkin 5Lymphoma, Large B-Cell, Diffuse 5Liver Neoplasms 5Dendritic Cell Sarcoma, Interdigitating 5Breast Neoplasms 5Sarcoma 4Peritoneal Neoplasms 4

Interventions

Carboplatin 44Paclitaxel 42Cisplatin 20Topotecan 17Gemcitabine 16Docetaxel 13Bevacizumab 13liposomal doxorubicin 7olaparib 6Cyclophosphamide 6pembrolizumab 5Surgical Procedures, Operative 5Filgrastim 5Etoposide 5Drug Therapy 5Amifostine 5sargramostim 4oregovomab 4catumaxomab 4anlotinib 4Imatinib Mesylate 4Hyperthermic Intraperitoneal Chemotherapy 4rucaparib 3pegfilgrastim 3niraparib 3ixabepilone 3aldesleukin 3Standard of Care 3Peripheral Blood Stem Cell Transplantation 3Oxaliplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Ovarian Epithelial × Leucovorin × Clear all
NCT00004206 2014-06-24

Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡